Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.
Montgomery
Bruce
B
Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington 98109, USA. rbmontgo@u.washington.edu
Lavori
Philip
P
Garzotto
Mark
M
Lee
Kelvin
K
Brophy
Mary
M
Thaneemit-Chen
Surai
S
Kelly
William
W
Basler
Joseph
J
Ringer
Robert
R
Yu
Wei
W
Whittemore
Alice
A
Lin
Daniel W
DW
D017024:Chemotherapy, Adjuvant / Q000379:methods; D017326:Clinical Trials, Phase III as Topic; D018572:Disease-Free Survival; D000077143:Docetaxel; D006787:Hospitals, Veterans; D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery*; D011859:Radiography; D011878:Radiotherapy / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012306:Risk; D043823:Taxoids / Q000008:administration & dosage*; D016896:Treatment Outcome
D043823:Taxoids; D000077143:Docetaxel